jarlife journal
Sample text

AND option

OR option

All issues

Back to all journals

01/2024 journal articles

ASSOCIATION BETWEEN MODIFIABLE RISK FACTORS AND LEVELS OF BLOOD-BASED BIOMARKERS OF ALZHEIMER’S AND RELATED DEMENTIAS IN THE LOOK AHEAD COHORT

K.M. Hayden, M.M. Mielke, J.K. Evans, R. Neiberg, D. Molina-Henry, M. Culkin, S. Marcovina, K.C. Johnson, O.T. Carmichael, S.R. Rapp, B.C. Sachs, J. Ding, H. Shappell, L. Wagenknecht, J.A. Luchsinger, M.A. Espeland

J Aging Res & Lifestyle 2024;13:1-21

Show summaryHide summary

BACKGROUND: Emerging evidence suggests that a number of factors can influence blood-based biomarker levels for Alzheimer’s disease (AD) and Alzheimer’s related dementias (ADRD). We examined the associations that demographic and clinical characteristics have with AD/ADRD blood-based biomarker levels in an observational continuation of a clinical trial cohort of older individuals with type 2 diabetes and overweight or obesity. METHODS: Participants aged 45-76 years were randomized to a 10-year Intensive Lifestyle Intervention (ILI) or a diabetes support and education (DSE) condition. Stored baseline and end of intervention (8-13 years later) plasma samples were analyzed with the Quanterix Simoa HD-X Analyzer. Changes in Aβ42, Aβ40, Aβ42/Aβ40, ptau181, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were evaluated in relation to randomization status, demographic, and clinical characteristics. RESULTS: In a sample of 779 participants from the Look AHEAD cohort, we found significant associations between blood-based biomarkers for AD/ADRD and 15 of 18 demographic (age, gender, race and ethnicity, education) and clinical characteristics (APOE, depression, alcohol use, smoking, body mass index, HbA1c, diabetes duration, diabetes treatment, estimated glomerular filtration rate, hypertension, and history of cardiovascular disease) . CONCLUSIONS: Blood-based biomarkers of AD/ADRD are influenced by common demographic and clinical characteristics. These factors should be considered carefully when interpreting these AD/ADRD blood biomarker values for clinical or research purposes.

CITATION:
K.M. Hayden ; M.M. Mielke ; J.K. Evans ; R. Neiberg ; D. Molina-Henry ; M. Culkin ; S. Marcovina ; K.C. Johnson ; O.T. Carmichael ; S.R. Rapp ; B.C. Sachs ; J. Ding ; H. Shappell ; L. Wagenknecht ; J.A. Luchsinger ; M.A. Espeland (2024): Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer’s and Related Dementias in the Look AHEAD Cohort. The Journal of Aging and Lifestyle (JARLife). http://dx.doi.org/10.14283/jarlife.2024.1

OPEN ACCESS

Download PDF (1.61 Mo) View HTML

Read more...